News Operational Efficiency AI in Oncology

Real-Time Multimodal AI for Proactive, Individualized Care

April 23, 2026 By Julia Cipriano, MS, CMPP 5 min read
Share Share via Email Share on Facebook Share on LinkedIn Share on Twitter

5 Key Takeaways

  • 1

    Real-time multimodal AI can transform cancer care from reactive to proactive, improving consistency and quality across patient visits.

  • 2

    Current alert systems miss 40% of cases and have low adoption rates due to alarm fatigue and ineffective generic models.

  • 3

    The Bayesian Health platform integrates multimodal data and employs specialized models to enhance clinical workflows and patient outcomes.

  • 4

    In a sepsis case study, the platform improved sensitivity and reduced alert volume, leading to significant clinical impact and adoption rates.

  • 5

    Successful adoption of AI tools in diverse settings requires adaptive technology and workflow design that facilitates ease of use.

ASCO AI in Oncology is published by Conexiant under a license arrangement with the American Society of Clinical Oncology, Inc. (ASCO®). The ideas and opinions expressed in ASCO AI in Oncology do not necessarily reflect those of Conexiant or ASCO. For more information, see Policies.

KOL Commentary
Watch

Related Content